Rhythm Pharmaceuticals, Inc. (FRA:1RV)
Germany
· Delayed Price · Currency is EUR 87.00
+2.50 (2.96%)
At close: Dec 5, 2025
Rhythm Pharmaceuticals Revenue
Rhythm Pharmaceuticals had revenue of $51.30M USD in the quarter ending September 30, 2025, with 54.28% growth. This brings the company's revenue in the last twelve months to $174.33M, up 54.92% year-over-year. In the year 2024, Rhythm Pharmaceuticals had annual revenue of $130.13M with 68.06% growth.
Revenue (ttm)
$174.33M
Revenue Growth
+54.92%
P/S Ratio
40.38
Revenue / Employee
$616.02K
Employees
283
Market Cap
6.00B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |